Effects of Implementing a High Potassium Diet in Heart Failure Patients
NCT03059680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-02-20
Summary
This study evaluates the safety and physiologic effects of increasing dietary potassium intake in individuals with heart failure.
Conditions
Interventions
- OTHER
-
High potassium diet
An increase in consumption of high potassium fruits and vegetables
Sponsors & Collaborators
-
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-01-31
More Related Trials
-
Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
NCT00405639 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
NCT00405548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Examination of Potassium Levels in Saliva in ESRD Patients
NCT02596386 ·Status: UNKNOWN
-
Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
NCT00972569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
NCT00170183 ·Status: COMPLETED ·Phase: PHASE3
-
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
NCT00119691 ·Status: COMPLETED ·Phase: PHASE2
-
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
NCT06736184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
NCT01455974 ·Status: COMPLETED ·Phase: NA
-
Empagliflozin in Acute Heart Failure
NCT05305495 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction
NCT00818701 ·Status: TERMINATED ·Phase: PHASE1
-
The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure
NCT00953303 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure
NCT04334668 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124 ·Status: COMPLETED ·Phase: NA
-
Sodium-Endothelial Function-CKD Study
NCT00141622 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
NCT00843154 ·Status: TERMINATED ·Phase: PHASE3
-
Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern
NCT03603938 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study
NCT04466969 ·Status: COMPLETED
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
NCT04040959 ·Status: RECRUITING ·Phase: PHASE2
-
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
NCT06233695 ·Status: COMPLETED
-
Effect of Varied Dialysate Bicarbonate Levels on Phosphate and Potassium Removal
NCT01930370 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
NCT01130597 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
NCT01028170 ·Status: COMPLETED ·Phase: PHASE3
-
Kidney Sodium Content in Cardiorenal Patients
NCT04170855 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prednisone for Decompensated Congestive Heart Failure
NCT00369044 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3